20 October 2025 in European Journal of Surgical Oncology
19 March 2026 in European Journal of Surgical Oncology
The prognostic impact of vascular resection in intrahepatic cholangiocarcinoma (iCCA) remains uncertain, particularly in the context of advanced disease requiring complex surgery. This study evaluated the association between vascular resection and long-term survival and examined how tumor biology, assessed with tumor burden score (TBS) and CA19-9, influenced outcomes. Patients who underwent upfront curative-intent hepatectomy for iCCA were identified from an international multi-institutional database. Multivariable Cox regression assessed overall (OS) and recurrence-free survival (RFS). Among patients undergoing vascular resection, biologic heterogeneity was explored using optimized TBS and CA19-9 cutoffs to define biologic risk subgroups. Among 1757 patients, 9.7% (n = 171) required major vascular resection. These patients were more likely to have bilateral tumors (29.2% vs. 21.3%), lymph node metastasis (33.9% vs. 24.8%), and T3/T4 tumors (57.3% vs. 27.6%) (all p < 0.05). Vascular resection was not an independent predictor of OS (aHR 1.11, 95% CI 0.82-1.51) or RFS (HR 1.02, 95% CI 0.81-1.27). Within the vascular resection cohort, higher TBS (aHR 1.11, 95% CI 1.03-1.19) and higher CA19-9 (log-transformed; aHR 1.16, 95% CI 1.02-1.32) were independently associated with worse OS. Five-year survival decreased stepwise from favorable to unfavorable biologic profiles. Patients with favorable biology demonstrated survival comparable to individuals undergoing hepatectomy without vascular resection. Major vascular resection did not independently worsen prognosis after iCCA hepatectomy. Instead, tumor biology-captured by TBS and CA19-9-was strongly associated with long-term outcomes, highlighting the importance of biologic risk stratification when considering vascular resection.